Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Citrate transporter" is a non-specific term for a family of membrane proteins that facilitate the movement of citrate across cellular or organelle membranes. In humans, two major types are recognized: (1) the mitochondrial tricarboxylate transport protein (SLC25A1/CTP), which exchanges citrate and malate across the mitochondrial inner membrane and is crucial for providing cytosolic citrate for lipid and sterol biosynthesis, and (2) the sodium-dependent citrate transporter (SLC13A5/NaCT), a plasma membrane protein involved in hepatic and neuronal citrate uptake. In plants and microbes, specialized citrate transporters such as those in the MATE family export citrate to detoxify metals or support unique metabolic needs. These proteins are emerging targets in metabolic disease, cancer, and plant bioengineering[1][2][3][4].
Inhibition of citrate uptake reduces cytoplasmic citrate and can suppress fatty acid and cholesterol biosynthesis. Inhibition of NaCT may affect neuronal and hepatic metabolism; CTP inhibition may impact mitochondrial function. In plants, modulation of citrate secretion alters aluminum tolerance.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tricarboxylate transport protein (mitochondrial) (CTP).